Company intelligence / Profile preview

Bioserve Biotechnologies

Hyderabad, Telangana, Indiabioserve.in ↗

Ownership: Private
Development stage: Commercial

Overview

Bioserve Biotechnologies is India's leading oligosynthesis and genomics services provider. It operates one of the largest commercial biorepositories of human clinical samples globally. The company offers custom oligonucleotide synthesis, DNA/RNA sequencing (Sanger and NGS), genotyping, gene expression analysis, molecular diagnostics—especially for early cancer detection—and supports academic/industry researchers with access to over 600,000 human biospecimens linked to clinical data. In 2014 it was acquired by REPROCELL Inc., Japan.

Modalities: DNA/RNA sequencing (Sanger and Next Generation Sequencing)Oligonucleotide synthesis
Industry: Molecular Diagnostics

Partnerships

BioMavericks Ltd. (UK distributor partnership for molecular biology products as of 2023)

Beyond the preview

Go deeper on Bioserve Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioserve Biotechnologies.

Explore the full profile